Arizona State Retirement System’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18M Buy
28,831
+533
+2% +$363K 0.09% 190
2026
Q1
$21.9M Sell
28,298
-934
-3% -$715K 0.13% 134
2025
Q4
$22.6M Sell
29,232
-1,766
-6% -$1.2M 0.12% 129
2025
Q3
$17.4M Sell
30,998
-224
-0.7% -$127K 0.09% 181
2025
Q2
$16.4M Sell
31,222
-462
-1% -$258K 0.09% 184
2025
Q1
$20.1M Buy
31,684
+460
+1% +$316K 0.13% 139
2024
Q4
$22.2M Buy
31,224
+185
+0.6% +$155K 0.14% 124
2024
Q3
$32.6M Sell
31,039
-254
-0.8% -$283K 0.21% 83
2024
Q2
$32.9M Buy
31,293
+550
+2% +$533K 0.22% 80
2024
Q1
$29.6M Buy
30,743
+712
+2% +$677K 0.2% 91
2023
Q4
$26.4M Sell
30,031
-508
-2% -$418K 0.2% 97
2023
Q3
$25.1M Sell
30,539
-192
-0.6% -$151K 0.21% 88
2023
Q2
$22.1M Buy
30,731
+1,493
+5% +$1.15M 0.18% 104
2023
Q1
$24M Buy
29,238
+31
+0.1% +$23.4K 0.22% 91
2022
Q4
$21.1M Sell
29,207
-158
-0.5% -$117K 0.2% 99
2022
Q3
$20.2M Buy
29,365
+88
+0.3% +$55.4K 0.21% 87
2022
Q2
$17.3M Buy
29,277
+268
+0.9% +$174K 0.17% 115
2022
Q1
$20.3M Buy
29,009
+222
+0.8% +$140K 0.16% 111
2021
Q4
$18.2M Sell
28,787
-403
-1% -$248K 0.14% 130
2021
Q3
$17.7M Sell
29,190
-308
-1% -$191K 0.14% 128
2021
Q2
$16.5M Sell
29,498
-51
-0.2% -$25.8K 0.13% 141
2021
Q1
$14M Sell
29,549
-614
-2% -$299K 0.12% 151
2020
Q4
$14.6M Sell
30,163
-512
-2% -$276K 0.13% 140
2020
Q3
$17.2M Buy
30,675
+6,981
+29% +$4.23M 0.17% 113
2020
Q2
$14.8M Buy
23,694
+9,137
+63% +$5.19M 0.21% 91
2020
Q1
$7.11M Sell
14,557
-443
-3% -$183K 0.12% 213
2019
Q4
$5.63M Buy
15,000
+79
+0.5% +$26.6K 0.07% 364
2019
Q3
$4.14M Sell
14,921
-36
-0.2% -$10.7K 0.05% 469
2019
Q2
$4.68M Sell
14,957
-93
-0.6% -$31K 0.05% 465
2019
Q1
$6.18M Sell
15,050
-897
-6% -$369K 0.07% 339
2018
Q4
$5.96M Sell
15,947
-3,258
-17% -$1.19M 0.08% 315
2018
Q3
$7.76M Buy
19,205
+195
+1% +$74.2K 0.07% 330
2018
Q2
$6.56M Sell
19,010
-108
-0.6% -$33.8K 0.07% 368
2018
Q1
$6.58M Sell
19,118
-400
-2% -$139K 0.07% 381
2017
Q4
$7.34M Buy
19,518
+518
+3% +$210K 0.07% 344
2017
Q3
$8.49M Buy
19,000
+100
+0.5% +$47.6K 0.1% 255
2017
Q2
$9.28M Buy
18,900
+100
+0.5% +$43.8K 0.13% 170
2017
Q1
$7.29M Buy
18,800
+100
+0.5% +$37.1K 0.1% 207
2016
Q4
$6.87M Buy
18,700
+100
+0.5% +$38K 0.1% 211
2016
Q3
$7.48M Sell
18,600
-500
-3% -$201K 0.11% 191
2016
Q2
$6.67M Sell
19,100
-2,100
-10% -$809K 0.09% 211
2016
Q1
$7.64M Buy
21,200
+300
+1% +$124K 0.1% 199
2015
Q4
$11.3M Sell
20,900
-300
-1% -$163K 0.15% 134
2015
Q3
$9.86M Buy
+21,200
New +$11.4M 0.14% 152
2014
Q4
$8.53M Buy
20,800
+300
+1% +$118K 0.1% 196
2014
Q3
$7.39M Sell
20,500
-2,300
-10% -$771K 0.09% 209
2014
Q2
$6.44M Buy
22,800
+900
+4% +$267K 0.08% 247
2014
Q1
$6.58M Sell
21,900
-600
-3% -$185K 0.08% 231
2013
Q4
$6.19M Sell
22,500
-400
-2% -$115K 0.08% 254
2013
Q3
$7.16M Buy
22,900
+700
+3% +$184K 0.09% 205
2013
Q2
$4.99M Buy
+22,200
New +$5.17M 0.07% 285

Other funds holding REGN

Arizona State Retirement System's REGN Position: Q2 2026 in Review

Arizona State Retirement System increased its Regeneron Pharmaceuticals (REGN) stake by 1.9% in Q2 2026, buying an estimated $363K and bringing the position to 28,831 shares worth $18M. The position accounts for 0.09% of the portfolio, ranked #190.

Arizona State Retirement System first reported a position in REGN in Q2 2013 and has held it in 51 quarters since. The position peaked at $32.9M in Q2 2024. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Arizona State Retirement System held 28,831 shares of Regeneron Pharmaceuticals worth $18M as of Q2 2026.
  • Arizona State Retirement System bought 533 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $363K.
  • Regeneron Pharmaceuticals made up 0.09% of Arizona State Retirement System's portfolio in Q2 2026, its #190 holding.
  • Arizona State Retirement System first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 51 quarters since.
  • Arizona State Retirement System's Regeneron Pharmaceuticals position peaked at $32.9M in Q2 2024.
  • 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Arizona State Retirement System's 13F filing for Q2 2026, filed 7 Aug 2026.